Följ
Luca Valenti
Luca Valenti
Associate Professor of Internal Medicine, Università degli Studi di Milano, Fondazione Ca' Granda
Verifierad e-postadress på unimi.it
Titel
Citeras av
Citeras av
År
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
M Eslam, PN Newsome, SK Sarin, QM Anstee, G Targher, ...
Journal of hepatology 73 (1), 202-209, 2020
29782020
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
M Eslam, AJ Sanyal, J George, A Sanyal, B Neuschwander-Tetri, ...
Gastroenterology 158 (7), 1999-2014. e1, 2020
24552020
Genomewide association study of severe Covid-19 with respiratory failure
Severe Covid-19 GWAS Group
New England Journal of Medicine 383 (16), 1522-1534, 2020
18482020
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, ...
Hepatology 78 (6), 1966-1986, 2023
10662023
Genetics and epigenetics of NAFLD and NASH: Clinical impact
M Eslam, L Valenti, S Romeo
Journal of hepatology 68 (2), 268-279, 2018
8902018
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes
AL Fracanzani, L Valenti, E Bugianesi, M Andreoletti, A Colli, E Vanni, ...
Hepatology 48 (3), 792-798, 2008
8682008
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
7162021
Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease
L Valenti, A Al‐Serri, AK Daly, E Galmozzi, R Rametta, P Dongiovanni, ...
Hepatology 51 (4), 1209-1217, 2010
6872010
Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes
D Frescas, L Valenti, D Accili
Journal of Biological Chemistry 280 (21), 20589-20595, 2005
6852005
The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent
RM Mancina, P Dongiovanni, S Petta, P Pingitore, M Meroni, R Rametta, ...
Gastroenterology 150 (5), 1219-1230. e6, 2016
6212016
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
P Dongiovanni, S Petta, C Maglio, AL Fracanzani, R Pipitone, E Mozzi, ...
Hepatology 61 (2), 506-514, 2015
5582015
Statin use and non-alcoholic steatohepatitis in at risk individuals
P Dongiovanni, S Petta, V Mannisto, RM Mancina, R Pipitone, V Karja, ...
Journal of hepatology 63 (3), 705-712, 2015
4422015
Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease
L Valenti, AL Fracanzani, P Dongiovanni, G Santorelli, A Branchi, E Taioli, ...
Gastroenterology 122 (2), 274-280, 2002
4342002
Advancing the global public health agenda for NAFLD: a consensus statement
JV Lazarus, HE Mark, QM Anstee, JP Arab, RL Batterham, L Castera, ...
Nature Reviews Gastroenterology & Hepatology 19 (1), 60-78, 2022
4282022
COVID-19 and liver disease
J Sun, A Aghemo, A Forner, L Valenti
Liver international 40 (6), 1278-1281, 2020
4042020
Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target
P Dongiovanni, AL Fracanzani, S Fargion, L Valenti
Journal of hepatology 55 (4), 920-932, 2011
3952011
PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells
C Pirazzi, L Valenti, BM Motta, P Pingitore, K Hedfalk, RM Mancina, ...
Human molecular genetics 23 (15), 4077-4085, 2014
3722014
Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study
L Valenti, AL Fracanzani, P Dongiovanni, E Bugianesi, G Marchesini, ...
Official journal of the American College of Gastroenterology| ACG 102 (6 …, 2007
3482007
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆
QM Anstee, R Darlay, S Cockell, M Meroni, O Govaere, D Tiniakos, ...
Journal of hepatology 73 (3), 505-515, 2020
3452020
HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease
L Valenti, AL Fracanzani, E Bugianesi, P Dongiovanni, E Galmozzi, ...
Gastroenterology 138 (3), 905-912, 2010
3322010
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20